NACE PhD Scholar Sophie Rosser published in Allergy

Published

Monday, September 8, 2025 - 12:00 PM

Having a food allergy can have a significant impact on a child's life.

A new systematic review has found oral immunotherapy (OIT) for children with food allergies leads to improved quality of life a year on from discontinuing treatment due to having achieved remission. But quality of life remained unchanged for children who continued while on treatment.

The review by Sophie Rosser, National Allergy Centre of Excellence (NACE) food allergy PhD Scholar based at Murdoch Children's Research Institute, focused on children who were allergic to peanuts, but also included those with a baked milk allergy.

Sophie said this was the most up-to-date look at quality of life in children after oral immunotherapy, showing the biggest improvements happened when treatment resulted in lasting protection and therapy could safely finish.

Key findings:

• OIT did not improve quality of life compared to control groups during time on treatment protocols
• But significant benefits arose 12-months post-treatment
• With achievement of peanut allergy remission following treatment being a likely key driver of wellbeing benefits.

This work was proudly supported by the NACE with valuable input from our Consumer Advisory Group.

Read Sophie's Systematic Review and Meta-Analysis of Oral Immunotherapy Effect on Food Allergy-Related Quality of Life published in Allergy.